Provided by Tiger Trade Technology Pte. Ltd.

AgeX Therapeutics Inc

11.10
0.0000
Volume:- -
Turnover:44.29K
Market Cap:27.76M
PE:-0.85
High:11.10
Open:11.10
Low:11.10
Close:11.10
52wk High:35.17
52wk Low:10.90
Shares:2.50M
Float Shares:606.40K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0212
EPS(LYR):-9.6973
ROE:306.76%
ROA:-81.88%
PB:5.08
PE(LYR):-1.14

Loading ...

Company Profile

Company Name:
AgeX Therapeutics Inc
Exchange:
AMEX
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.